COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 844: Articles 8431-8440  | Next

If you build it, will they use it? Use of a Digital Assistant for Self-Reporting of COVID-19 Rapid Antigen Test Results during Large Nationwide Community Testing Initiative
Herbert, C., Shi, Q., Kheterpal, V., Nowak, C., Suvarna, T., Durnan, B., Schrader, S., Behar, S., Naeem, S., Tarrant, S., Kalibala, B., Singh, A., Gerber, B., Barton, B., Lin, H., Cohen-Wolkowiez, M., Corbie-Smith, G., Kibbe, W., Marquez, J., Baek, J., Hafer, N., Gibson, L., O'Connor, L., Broach, J., Heetderks, W., McManus, D., Soni, A.
10.1101/2022.03.31.22273242 — Posted: 2022-04-01
Metabolic alkalosis and mortality in COVID-19
Jiang, Z.
10.1101/2022.04.01.22273291 — Posted: 2022-04-01
Emulation of epidemics via Bluetooth-based virtual safe virus spread: experimental setup, software, and data
Asanjarani, A., Shausan, A., Chew, K., Graham, T., Short, K. R., Nazarathy, Y., Henderson, S. G., Jansen, H. M., Taylor, P. G., Vuorinen, A., Yadav, Y., Ziedins, I.
10.1101/2022.03.31.22273262 — Posted: 2022-04-01
COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
Banerjee, J., Friedman, J. M., Klesse, L. J., Yohay, K., Jordan, J. T., Plotkin, S., Allaway, R. J., Blakeley, J. O.
10.1101/2022.03.31.22273208 — Posted: 2022-04-01
Effect of vaccination rates on the prevalence and mortality of COVID-19
Westerhout, J., Khataee, H., Neufeld, Z.
10.1101/2022.03.31.22273274 — Posted: 2022-04-01
Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine
Cho, A., Muecksch, F., Wang, Z., Ben Tanfous, T., DaSilva, J., Raspe, R., Johnson, B., Bednarski, E., Ramos, V., Schaefer-Babajew, D., Shimeliovich, I., Dizon, J., Yao, K.-H., Schmidt, F., Millard, K. G., Turroja, M., Jankovic, M., Oliveira, T. Y., Gazumyan, A., Gaebler, C., Caskey, M., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C.
10.1101/2022.03.31.486548 — Posted: 2022-04-01
What factors converged to create a COVID-19 hot-spot? Lessons from the South Asian community in Ontario.
Anand, S. S., Arnold, C., Bangdiwala, S. I., Bolotin, S., Bowdish, D., Chanchlani, R., de Souza, R., Desai, D., Kandasamy, S., Khan, F., Khan, Z., Langlois, M.-A., Limbachia, J., Lear, S., Loeb, M., Loh, L. C., Manoharan, B., Nakka, K., Pelchat, M., Punthakee, Z., Schulze, K. M., Williams, N. C., Wahi, G.
10.1101/2022.04.01.22273252 — Posted: 2022-04-01
Internet and mental health during the COVID-19 pandemic: Evidence from the UK
Quintana-Domeque, C., Zeng, J., Zhang, X.
10.1101/2022.04.01.22273299 — Posted: 2022-04-01
Consistent Pattern of Epidemic Slowing Across Many Geographies Led to Longer, Flatter Initial Waves of the COVID-19 Pandemic
Ben-Nun, M., Riley, P., Turtle, J. A., Riley, S.
10.1101/2022.03.31.22273267 — Posted: 2022-04-01
Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation: test negative case-control study
Stowe, J., Andrews, N., Kirsebom, F., Ramsay, M., Lopez Bernal, J.
10.1101/2022.04.01.22273281 — Posted: 2022-04-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).